Indication
Nasopharynx Carcinoma
2 clinical trials
2 products
1 drug
Clinical trial
A Single Arm Phase I/II Study of MK-3475 Combined With Vorinostat for Recurrent Unresectable and/or Metastatic Squamous Cell Head and Neck Cancer and Recurrent Unresectable and/or Metastatic Salivary Gland MalignanciesStatus: Completed, Estimated PCD: 2019-09-28
Product
PembrolizumabProduct
VorinostatClinical trial
A Phase II, Single-Arm Open-Label Study of the Combination of Atezolizumab and Bevacizumab in Rare Solid TumorsStatus: Active (not recruiting), Estimated PCD: 2025-09-30
Drug
Atezolizumab